title: The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease.
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Potaczek
authors.forename: Anetta
authors.initials: A
authors.lastname: Undas
authors.forename: Teresa
authors.initials: T
authors.lastname: Iwaniec
authors.forename: Andrew
authors.initials: A
authors.lastname: Szczeklik
mesh_terms: D000483:Alleles; D000792:Angiography; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000069059:Atorvastatin; D001794:Blood Pressure; D003324:Coronary Artery Disease / Q000235:genetics*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis / Q000096:biosynthesis; D005838:Genotype; D006487:Hemostasis; D006538:Heptanoic Acids / Q000494:pharmacology*; D006579:Heterozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics / Q000473:pathology; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D011758:Pyrroles / Q000494:pharmacology*; D000077583:Quinapril; D012306:Risk; D044005:Tetrahydroisoquinolines / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D005338:Fibrin Fibrinogen Degradation Products; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D044005:Tetrahydroisoquinolines; C036309:fibrin fragment D; D000069059:Atorvastatin; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril